Medication

WILMINGTON, Del.–(BUSINESS WIRE)–Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Jakafi XR™…

LITTLE ROCK (KATV) — An Arkansas father is calling for the sale of bulk over-the-counter medication to minors…

The MHRA has issued urgent new advice to people using nasal decongestant sprays The MHRA has issued a…

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for…

PwC’s consultants and bean counters in the US are used to trimming the fat from clients’ budgets, but…

(CNN) — Bayer has recalled travel-size bottles of its Afrin original nasal spray. The bottles do not have…

TORONTO — Health Canada has approved the second generic version of brand-name Ozempic, this one manufactured by Canadian…

Listen to this article Estimated 2 minutes The audio version of this article is generated by AI-based technology.…

As Health Secretary Robert F. Kennedy Jr. sets out to rein in the use of psychiatric medications, a…

OTTAWA, May 1 (Reuters) – The ‌Canadian ‌health regulator said on Friday that it had ‌approved Canada-based ⁠Apotex’s…

Bayer issued a recall for nearly 800,000 units of Afrin nasal spray bottles after the packaging was found…

Health Canada approves 2nd generic version of Ozempic — and it’s Canadian CTV NewsCanada approves first generic version of…

Incyte Announces FDA Approval of Jakafi XR™ (ruxolitinib) Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease